Viatris

Traded on the St. Petersburg Stock Exchange
Viatris is an American healthcare company formed through the combination of Mylan and Upjohn in November 2020. It manufactures and distributes various medicines for patients in the United States and internationally. The company is headquartered in Canonsburg, Pennsylvania.
Viatris stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Viatris balance sheet

Report period2019 2020 2021 2022 2023 Q2 24
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Viatris cash flows

Report period2019 2020 2021 2022 2023 Q2 24 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Viatris multipliers

Report period2019 2020 2021 2022 2023 Q2 24 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Viatris profitability

Report period2019 2020 2021 2022 2023 Q2 24 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Viatris assets
Viatris cash flows
Viatris dividends
4.6%

Viatris dividend policy

The company pays dividends quarterly

Viatris shares

TickerNameTypeNominal valueISINPrice
VTRS:USViatrisCommon share-US92556V1061$11.82
Viatris news
27.02.2023
The Viatris Board of Directors announced a quarterly dividend of $0.12 per share. The last day to buy securities to receive the dividend is March 7, 2023. The annual dividend yield may reach 4.33%.
27.02.2023
Viatris' GAAP net income for 2022 was $2.079 billion, compared to a loss of $1.269 billion in the previous year. Revenue fell 9.1% to $16.263 billion from $17.886 billion a year earlier.
08.11.2022
The Viatris Board of Directors announced a quarterly dividend of $0.12 per share. The last day to buy securities to receive the dividend is November 21, 2022. The annual dividend yield may reach 4.12%.
07.11.2022
Viatris' GAAP net income for 9 months of 2022 was $1.067 billion, compared to a loss of $1.005 billion in the previous year. Revenue decreased by 8.5% to $12.387 billion from $13.545 billion a year earlier.
General information
Company nameViatris
Tags#pharmacy, #s&p500 index
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address1000 Mylan Blvd Canonsburg, PA 15317 United States
Mailing address1000 Mylan Blvd Canonsburg, PA 15317 United States
Websiteinvestor.viatris.com
Information disclosurewww.sec.gov